Maven Securities »

Eyepoint Pharmaceuticals shares owned by Maven Securities

Quarter-by-quarter ownership of Eyepoint Pharmaceuticals (EYPT) shares owned by Maven Securities from 13F filings

Historical chart of Maven Securities investment in Eyepoint Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eyepoint Pharmaceuticals held by Maven Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eyepoint Pharmaceuticals by Maven Securities

Quarter filed Position value Share count Share price at filing
2023-12-31 $231k 10k 23.11
2021-12-31 $918k 75k 12.24

More positions owned by Maven Securities

Ishares Tr Call Call Option
Ishares Tr Put Put Option
Vaneck Etf Trust Call Call Option
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vaneck Etf Trust Put Put Option
Invesco Qqq Tr Put Put Option
Spdr S&p 500 Etf Tr Call Call Option
Invesco Qqq Tr Call Call Option
Spdr S&p 500 Etf Tr Put Put Option
Ishares Tr Put Put Option
Select Sector Spdr Tr Put Put Option
United States Stl Corp Put Put Option
Splunk Call Call Option
United States Stl Corp Call Call Option
Capri Holdings Put Put Option

View all positions for Maven Securities

Top funds holding Eyepoint Pharmaceuticals

Cormorant Asset Management
Franklin Resources
T. Rowe Price Associates
Vanguard Group
Citadel Advisors
Perceptive Advisors
Millennium Management
Ikarian Capital
Deutsche Bank Aktiengesellschaft
Federated Investors
Fiera Capital Corporation
Laurion Capital Management
UBS Group
Goldman Sachs Group
Oracle Investment Management

View all funds holding Eyepoint Pharmaceuticals